Clinical Trial Update: Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating apixaban versus vitamin K antagonist therapy during atrial fibrillation catheter ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Coumadin (warfarin)
• Eliquis (apixaban)

Snippet

Sponsor: Atrial Fibrillation Network | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED